Multitargeted therapy of cancer by green tea polyphenols
Top Cited Papers
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 269 (2) , 269-280
- https://doi.org/10.1016/j.canlet.2008.04.014
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Tea polyphenols for health promotionLife Sciences, 2007
- (−)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-κB signalingLife Sciences, 2007
- Epigallocatechin Gallate Inhibits Phorbol Ester‐Induced Activation of NF‐κB and CREB in Mouse SkinAnnals of the New York Academy of Sciences, 2007
- Epigallocatechin-3-Gallate Inhibits Secretion of TNF-α, IL-6 and IL-8 through the Attenuation of ERK and NF-κB in HMC-1 CellsInternational Archives of Allergy and Immunology, 2006
- EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cellsBiochemical and Biophysical Research Communications, 2005
- Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling PathwayJournal of Biological Chemistry, 2004
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002
- Inhibition of UVB-Induced Oxidative Stress-Mediated Phosphorylation of Mitogen-Activated Protein Kinase Signaling Pathways in Cultured Human Epidermal Keratinocytes by Green Tea Polyphenol (−)-Epigallocatechin-3-gallateToxicology and Applied Pharmacology, 2001
- Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastomaFEBS Letters, 2000
- Biotransformation of (-)-Epicatechin 3-O-Gallate by Human Intestinal Bacteria.CHEMICAL & PHARMACEUTICAL BULLETIN, 1997